Ep0093 889 — Boston, Massachusetts

Ep0093 889 is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Ep0093 889 has participated in 1 clinical trials.

Therapeutic areas: Drug-Resistant Epilepsy, Focal-Onset Seizures.

Sponsors: UCB Biopharma SRL.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0093 889?

Ep0093 889 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0093 889 conducted?

Ep0093 889 has 1 clinical trials on record. Their work covers Drug-Resistant Epilepsy, Focal-Onset Seizures.

Is Ep0093 889 accredited by Crixeo Clinical Trials?

Ep0093 889 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0093 889?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.